Linking etiologies in humans and animal models: studies of autism.
about
What We Have Learned about Autism Spectrum Disorder from Valproic AcidThe CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autismGenetic Syndromes, Maternal Diseases and Antenatal Factors Associated with Autism Spectrum Disorders (ASD)From genes to environment: using integrative genomics to build a "systems-level" understanding of autism spectrum disordersImpaired Processing in the Primary Auditory Cortex of an Animal Model of Autism.The Intense World Theory – A Unifying Theory of the Neurobiology of AutismGenetic aspects of autism spectrum disorders: insights from animal modelsThe ups and downs of Wnt signaling in prevalent neurological disordersInfant siblings and the investigation of autism risk factorsNeuronal connectivity as a convergent target of gene × environment interactions that confer risk for Autism Spectrum DisordersCritical periods of vulnerability for the developing nervous system: evidence from humans and animal modelsPre-clinical models of neurodevelopmental disorders: focus on the cerebellumPrenatal VPA Exposure and Changes in Sensory Processing by the Superior ColliculusDeficient brainstem encoding of pitch in children with Autism Spectrum DisordersIncreased BDNF expression in fetal brain in the valproic acid model of autism.Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism.In utero exposure to valproic acid changes sleep in juvenile rats: a model for sleep disturbances in autism.Abnormal emotional learning in a rat model of autism exposed to valproic acid in utero.Animal models of restricted repetitive behavior in autismMinor physical anomalies in children with autism spectrum disorders.Review article: the concept of entero-colonic encephalopathy, autism and opioid receptor ligands.Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism.Neuroimaging endophenotypes in animal models of autism spectrum disorders: lost or found in translation?The intense world syndrome--an alternative hypothesis for autismDifferences between children and adults: implications for risk assessment at California EPA.Decreased mTOR signaling pathway in human idiopathic autism and in rats exposed to valproic acid.The developing brain and the environment: an introductionAltered behavioral development in Nrf2 knockout mice following early postnatal exposure to valproic acid.Dermatologic and nondermatologic uses of thalidomide.Disruption in the inhibitory architecture of the cell minicolumn: implications for autism.Predictable enriched environment prevents development of hyper-emotionality in the VPA rat model of autismElevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid.Review of animal models for autism: implication of thyroid hormone.Advances in behavioral genetics: mouse models of autism.Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic Acid animal model of autism.General developmental health in the VPA-rat model of autismAutism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses.Increased expression of fatty acid synthase and acetyl-CoA carboxylase in the prefrontal cortex and cerebellum in the valproic acid model of autismEarly behavioral intervention, brain plasticity, and the prevention of autism spectrum disorder.Increased IgG4 levels in children with autism disorder.
P2860
Q21284783-B1285CF9-66BF-4F1C-ABB3-5624B2F68218Q24553624-0D7FD67C-0611-4EBF-9938-AEC168A23A8EQ26741618-97D317ED-B783-44C9-8DAD-4EEAAAE94F85Q26825821-D9AE0351-D680-4DD4-AB2E-33696667F4EDQ27308689-3A7F8FAD-6ED7-4AFD-9131-9BDD410451B1Q27500386-D4BE91E5-EF2C-494C-954D-886482B072ECQ27687011-2DAB2331-CB8D-426F-A9A6-2D97A26D8CF1Q28277009-1E2B33B3-7A7A-4471-AE7B-33768E5A3788Q28388355-A10B7068-5E3A-4F61-A78A-D813C64F43BBQ28396205-28465D74-D7E2-4609-AFFE-84AA05EAA3B2Q29547388-E68CFE0D-CEBF-465A-8E80-6F4A24A42EDCQ30436913-4A95E5E7-EE0A-46C4-9DAA-57A45CF268CAQ30473609-3A2C3BE5-DF57-4B85-851C-6C9AA48785DCQ30487709-60F4BF6E-15E3-4F7F-A5C6-0C335D439F4BQ33560820-52901A7E-5420-4460-8680-275404F37BF6Q33987401-74BD8DCA-AA4E-4A3D-BEB1-2567AC00D53EQ34125907-2166FC00-A867-4C83-A4D1-23C37C74F9E5Q34495960-6877E6C5-186C-414B-949F-5764BBC40C56Q34568411-7DA316FE-14C5-45ED-B32F-59C8E564B620Q34575629-93AAF272-3081-4FDB-91E2-1FBCB0F2A71FQ34585320-49F85D40-E692-4F62-B9D2-AE933AE96D4CQ34588189-D68657D2-D6E5-4906-A94B-200FC9078CBFQ34817846-5E330413-25AE-4FC6-AE03-7C98CC58AC70Q34871941-81536EB4-820B-41F4-BA33-EAA2C99B49F1Q34978971-FB89C2C0-8B11-4C55-BECA-28B75A03FEACQ35017799-095CEB3E-D231-48B7-9DC5-132DC17FB167Q35134560-C70DE87D-A377-4E40-9A5B-A5A711CF7F0FQ35200121-3789C066-BF33-45BD-9006-469BA027D4B2Q35201057-47907F09-1C30-4E2B-AC1E-8A21EFA9534AQ35609013-7CDDB773-349F-4860-87B8-915EDD8BB6C6Q35675589-DE77BD8D-51AC-4106-9C53-9C337241F458Q35941298-74C63B9D-08CB-48FF-9E0D-CF651B90E628Q36462150-431766E0-CABC-4F37-943B-5EE938A06ED7Q36937876-3F94C735-8514-4F3E-9321-3DE990C53A44Q36966253-D7D9FCCA-4B18-4BEC-AABE-AF6ED242C2D9Q37039400-AE6DCAB3-BF46-40B2-8F7D-3710755FF5BBQ37068738-2287C88F-10DF-4A32-AE1F-787BB2512B82Q37204659-A17ECF06-03CE-4853-8D29-5F952333AACAQ37208939-DBF3F1D5-68B5-460D-8E04-E668E465786DQ37227405-E7813595-9585-4DF6-B67D-1B0C7DD07BCB
P2860
Linking etiologies in humans and animal models: studies of autism.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Linking etiologies in humans and animal models: studies of autism.
@en
type
label
Linking etiologies in humans and animal models: studies of autism.
@en
prefLabel
Linking etiologies in humans and animal models: studies of autism.
@en
P2093
P1476
Linking etiologies in humans and animal models: studies of autism.
@en
P2093
P304
P356
10.1016/S0890-6238(97)80001-U
P577
1997-03-01T00:00:00Z